These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6090362)

  • 1. Dose and interval relationship for the interaction of WR-2721 and nitrogen mustard with normal and malignant cells.
    Valeriote F; Grates HE
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1561-4. PubMed ID: 6090362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection and potentiation of nitrogen mustard cytotoxicity by WR-2721.
    Valeriote F; Tolen S
    Cancer Res; 1982 Nov; 42(11):4330-1. PubMed ID: 6290032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of nitrogen mustard cytotoxicity to leukemia cells by sulfur-containing compounds administered in vivo.
    Valeriote F; Grates HE
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1165-9. PubMed ID: 3744935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of nitrogen mustard cytotoxicity by disulfiram, diethyldithiocarbamic acid, and diethylamine in mice.
    Valeriote F; Grates HE
    Cancer Res; 1989 Dec; 49(23):6658-61. PubMed ID: 2555050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of WR2721 on DNA cross-linking by nitrogen mustard in normal mouse bone marrow and leukemia cells in vivo.
    DeNeve WJ; Everett CK; Suminski JE; Valeriote FA
    Cancer Res; 1988 Nov; 48(21):6002-5. PubMed ID: 2844397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential protection of normal and malignant tissues against the cytotoxic effects of mechlorethamine.
    Yuhas JM
    Cancer Treat Rep; 1979 Jun; 63(6):971-6. PubMed ID: 223759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of WR-151327: an orally active chemotherapy protector.
    Green D; Bensely D; Schein P
    Cancer Res; 1994 Feb; 54(3):738-41. PubMed ID: 8306335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of spermatogonial survival and testicular function by WR-2721 against high and low doses of radiation.
    Meistrich ML; Finch MV; Hunter N; Milas L
    Int J Radiat Oncol Biol Phys; 1984 Nov; 10(11):2099-107. PubMed ID: 6092308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
    Milas L; Hunter N; Reid BO; Thames HD
    Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by Wr-2721.
    Wasserman TH; Phillips TL; Ross G; Kane LJ
    Cancer Clin Trials; 1981; 4(1):3-6. PubMed ID: 6260393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioprotection of mouse skin vasculature and the RIF-1 fibrosarcoma by WR-2721.
    Penhaligon M
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1541-4. PubMed ID: 6090358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of mice against fission neutron irradiation by WR-2721 or WR-151327.
    Steel LK; Jacobs AJ; Giambarresi LI; Jackson WE
    Radiat Res; 1987 Mar; 109(3):469-78. PubMed ID: 3031721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo protection against phototoxic side effects of photodynamic therapy by radioprotective agents WR-2721 and WR-77913.
    Dillon J; Kennedy JC; Pottier RH; Roberts JE
    Photochem Photobiol; 1988 Aug; 48(2):235-8. PubMed ID: 2851844
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection of murine foot tissue and transplantable tumor against Photofrin-II-mediated photodynamic sensitization with WR-2721.
    Bellnier DA; Dougherty TJ
    J Photochem Photobiol B; 1989 Nov; 4(2):219-25. PubMed ID: 2556509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the protective effects of three phosphorothioate radioprotectors in the RIF-1 tumor.
    Rasey JS; Krohn KA; Magee S; Nelson N; Chin L
    Radiat Res; 1986 Nov; 108(2):167-75. PubMed ID: 3024202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of mouse tissues to neutron and gamma radiation: protection by WR-3689 and WR-77913.
    Rasey JS; Magee S; Nelson N; Chin L; Krohn KA
    Radiother Oncol; 1990 Feb; 17(2):167-73. PubMed ID: 2157242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome protection by WR-2721 and MPG-single and combination treatments.
    Thomas B; Devi PU
    Strahlenther Onkol; 1987 Dec; 163(12):807-10. PubMed ID: 2827332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the radioprotective effects of YM-08310 (= WR-2721) Part 1: Radioprotective effects of YM-08310 on normal and malignant tissues in mice].
    Tanaka Y; Akagi K; Hasegawa T; Nakazawa M; Harima K; Murata T; Sawada S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 May; 43(5):700-9. PubMed ID: 6312407
    [No Abstract]   [Full Text] [Related]  

  • 19. Sodium hydrogen-S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913): toxicity and bone marrow radioprotection.
    Mendiondo OA; Connor AM; Grigsby P
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):553-5. PubMed ID: 6286552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioprotective effect of WR-2721 on haematopoiesis in mice. I. Quantitative changes in haematopoiesis.
    Brezáni P; Macková N
    Radiobiol Radiother (Berl); 1988; 29(5):587-93. PubMed ID: 2852382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.